Hisashi Kosaka, MD/PhD
Postdoctoral Fellow
Boston University School of Medicine
Dept of Anatomy & Neurobiology




Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kosaka H, Kaibori M, Chu DI, Stucchi AF, Sekimoto M. Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation. J Surg Res. 2021 Oct 09; 270:49-57. PMID: 34638093
     
  2. Kosaka H, Satoi S, Kono Y, Yamamoto T, Hirooka S, Yamaki S, Hashimoto D, Sakaguchi T, Sekimoto M. Estimation of the Degree of Surgical Difficulty Anticipated for Pancreatoduodenectomy: Preoperative and Intraoperative Factors. J Hepatobiliary Pancreat Sci. 2021 Oct 01. PMID: 34596977
     
  3. Ueno M, Komeda K, Kosaka H, Nakai T, Nomi T, Iida H, Tanaka S, Ikoma H, Matsuda K, Hirokawa F, Matsumoto M, Hokuto D, Mori H, Morimura R, Kaibori M, Yamaue H, Kubo S. Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study. Int J Surg. 2021 Sep 15; 94:106106. PMID: 34536602
     
  4. Ishizaki M, Kaibori M, Matsushima H, Kosaka H, Matsui K, Sekimoto M. Long-term complete response to lenvatinib in a patient with unresectable hepatocellular carcinoma. Clin J Gastroenterol. 2021 Sep 04. PMID: 34480729
     
  5. Kaibori M, Matsushima H, Ishizaki M, Kosaka H, Matsui K, Nakatani M, Kariya S, Yamaguchi T, Yoshida K, Yoshii K, Sekimoto M. The Impact of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with Major Vascular Invasion. Cancer Invest. 2021 Aug 26; 1-9. PMID: 34236269
     
  6. Ryota H, Ishida M, Ebisu Y, Yanagimoto H, Yamamoto T, Kosaka H, Hirooka S, Yamaki S, Kotsuka M, Matsui Y, Tsuta K, Satoi S. Clinicopathological characteristics of pancreatic ductal adenocarcinoma with invasive micropapillary carcinoma component with emphasis on the usefulness of PKC? immunostaining for detection of reverse polarity. Oncol Lett. 2021 Jul; 22(1):525. PMID: 34055090; PMCID: PMC8138900; DOI: 10.3892/ol.2021.12786;
     
  7. Kosaka H, Kaibori M, Matsui K, Ishizaki M, Matsushima H, Sekimoto M. Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic Cholangiocarcinoma. Asian Pac J Cancer Prev. 2021 May 01; 22(5):1485-1493. PMID: 34048177; PMCID: PMC8408380; DOI: 10.31557/APJCP.2021.22.5.1485;
     
  8. Kaibori M, Matsushima H, Ishizaki M, Kosaka H, Matsui K, Kariya S, Yoshii K, Sekimoto M. The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma. Asian Pac J Cancer Prev. 2021 Apr 01; 22(4):1217-1224. PMID: 33906315; PMCID: PMC8325117; DOI: 10.31557/APJCP.2021.22.4.1217;
     
  9. Kaibori M, Kosaka H, Matsui K, Ishizaki M, Matsushima H, Tsuda T, Hishikawa H, Okumura T, Sekimoto M. Near-Infrared Fluorescence Imaging and Photodynamic Therapy for Liver Tumors. Front Oncol. 2021; 11:638327. PMID: 33718233; PMCID: PMC7947679; DOI: 10.3389/fonc.2021.638327;
     
  10. Kaibori M, Matsushima H, Ishizaki M, Kosaka H, Matsui K, Ogawa A, Yoshii K, Sekimoto M. Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma. Cancers (Basel). 2021 Feb 17; 13(4). PMID: 33671388; PMCID: PMC7922697; DOI: 10.3390/cancers13040842;
     
Showing 10 of 33 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 33 publications over 11 distinct years, with a maximum of 11 publications in 2021

YearPublications
20022
20051
20081
20131
20142
20162
20172
20184
20195
20202
202111

Contact for Mentoring:

Kosaka's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department